These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8963673)

  • 21. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies.
    Grigoriadis DE; De Souza EB
    J Biol Chem; 1988 Aug; 263(22):10927-31. PubMed ID: 2839512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.
    Ross PC; Kostas CM; Ramabhadran TV
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1836-42. PubMed ID: 7811272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptors.
    Zhang G; Huang N; Li YW; Qi X; Marshall AP; Yan XX; Hill G; Rominger C; Prakash SR; Bakthavatchalam R; Rominger DH; Gilligan PJ; Zaczek R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):57-69. PubMed ID: 12649353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing factor stimulants adenylate cyclase activity in the anterior pituitary gland.
    Labrie F; Gagné B; Lefèvre G
    Life Sci; 1982 Sep; 31(11):1117-21. PubMed ID: 6292603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses.
    Wynn PC; Harwood JP; Catt KJ; Aguilera G
    Endocrinology; 1985 Apr; 116(4):1653-9. PubMed ID: 2982594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.
    Vita N; Laurent P; Lefort S; Chalon P; Lelias JM; Kaghad M; Le Fur G; Caput D; Ferrara P
    FEBS Lett; 1993 Nov; 335(1):1-5. PubMed ID: 8243652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.
    Rühmann A; Köpke AK; Dautzenberg FM; Spiess J
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10609-13. PubMed ID: 8855226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of human urocortin.
    Donaldson CJ; Sutton SW; Perrin MH; Corrigan AZ; Lewis KA; Rivier JE; Vaughan JM; Vale WW
    Endocrinology; 1996 May; 137(5):2167-70. PubMed ID: 8612563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1.
    Heinrich N; Meyer MR; Furkert J; Sasse A; Beyermann M; Bönigk W; Berger H
    Endocrinology; 1998 Feb; 139(2):651-8. PubMed ID: 9449637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase.
    Holmes MC; Antoni FA; Szentendrei T
    Neuroendocrinology; 1984 Aug; 39(2):162-9. PubMed ID: 6089019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2).
    Bonk I; Rühmann A
    Eur J Biochem; 2002 Nov; 269(21):5288-94. PubMed ID: 12392562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization.
    Grigoriadis DE; De Souza EB
    Peptides; 1989; 10(1):179-88. PubMed ID: 2546128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri.
    Palchaudhuri MR; Hauger RL; Wille S; Fuchs E; Dautzenberg FM
    J Neuroendocrinol; 1999 Jun; 11(6):419-28. PubMed ID: 10336722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
    Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
    J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with corticotropin-releasing factor.
    Webster EL; Tracey DE; De Souza EB
    Endocrinology; 1991 Nov; 129(5):2796-8. PubMed ID: 1834455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.